Table 2. Characteristics of Ukrainian patients tested positive for carbapenem-resistant Gram-negative bacteria on the day of admittance, Frankfurt am Main, Germany, March–June 2022 (n = 10).
| Patient | Age group (years)a | WI | MDRGN+CR bacteria | Carbapenemase(s) | Sequence type | Plasmid profile |
|---|---|---|---|---|---|---|
| A | 0–4 | No | Acinetobacter baumannii | OXA-72 | 78 | NT |
| B | Acinetobacter baumannii | OXA-72 | 78 | NT | ||
| C | 45–49 | Yes | Acinetobacter baumannii | OXA-23 | 2 | NT |
| Klebsiella pneumoniae | NDM-1 | 395 | NT | |||
| Pseudomonas aeruginosa | IMP-34 | 1047 | NT | |||
| D | 50–54 | Yes | Acinetobacter baumannii | OXA-23 + OXA-72 | NT | NT |
| Klebsiella pneumoniae | NDM-1 + OXA-244 | 392 | NT | |||
| Pseudomonas aeruginosa | NDM-1 | 773 | NT | |||
| E | 15–19 | Yes | Klebsiella pneumoniae | NDM-1 + OXA-48 | 23 | NT |
| Escherichia coli | NDM-5 | 46 | IncI1 MLST: ST57 | |||
| F | 50–54 | Yes | Klebsiella pneumoniae | NDM-1 | 23 | NT |
| G | 0–4 | No | Acinetobacter baumannii | OXA-72 | 78 | NT |
| Klebsiella pneumoniae | NDM-1 + OXA-48 | 147 | IncA/C cgPMLST: cgST1.2; IncA/C PMLST: ST1 | |||
| Escherichia coli | NDM-1 | 11240 | IncA/C cgPMLST: cgST1.2; IncA/C PMLST: ST1; IncI1 MLST: ST264 |
|||
| H | 65–69 | No | Escherichia coli | NDM-5 | 46 | IncI1 MLST: ST57 |
| I | 25–29 | No | Escherichia coli | OXA-48 | 354 | NT |
| J | 40–44 | No | Klebsiella pneumoniae | NDM-1 + OXA-48 | 147 | NT |
| Escherichia coli | KPC-3 + NDM-5 | 361 | NT | |||
| Proteus mirabilis | NDM-1 | NT | NT | |||
| Pseudomonas aeruginosa | GES-1 | 235 | NT |
CR: carbapenem-resistant; MDRGN: multidrug-resistant Gram-negative; NT: non-typable isolates; WI: war-related injuries.
a Age groups in accordance with the World Health Organization [19].